Nebula Research & Development LLC Wave Life Sciences Ltd. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Nebula Research & Development LLC holds 31,594 shares of WVE stock, worth $265,389. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,594
Previous 27,137
16.42%
Holding current value
$265,389
Previous $336 Million
23.95%
% of portfolio
0.02%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
203Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$153 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$105 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$69.4 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$56.6 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$53.4 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $729M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...